Omar Jawdat is a Neurology physician affiliated with University of Kansas Medical Center. OpenAlex indexes 101 publications with 1,585 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
University Of Kansas Medical Ctr
3599 Rainbow Blvd., Ms 2012
Kansas City, KS 661600001
Telephone
913-588-6970Registry record last updated 7 Feb 2017.
Clinical trials
- ALS Study Determining Various Biomarkers and Strength Comparison After Exercise
Sponsor: University of Kansas Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HOSPIRA, INC.Program year20251 payment
- HOSPIRA, INC.Program year20246 payments
- ARGENX US, INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
60.8%Gabapentinoids14.2%Pregabalin50%Gabapentin50%Part D≥22 patientsBenzothiazole11.5%Riluzole88%Teglutik12%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
18.2%Corticosteroid14.7%Prednisone100%Part D≥37 patientsAnticholinergic3.5%Atropine Sulfate58%Scopolamine42%Part D<11 patientsCancer & immunology
12.6%Folate Analog Metabolic Inhibitor5.8%Methotrexate100%Part D<11 patientsPurine Antimetabolite5.3%Azathioprine100%Part D≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Castro, MD
University of Kansas Medical Center
Jeffrey Burns, MD
University of Kansas Medical Center
Gary Gronseth, MD
University of Kansas Medical Center
Mazen Dimachkie, MD
University of Kansas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”